Induction of focal spongiform neurodegeneration in developmentally resistant mice by implantation of murine retrovirus-infected microglia - PubMed (original) (raw)
Induction of focal spongiform neurodegeneration in developmentally resistant mice by implantation of murine retrovirus-infected microglia
W P Lynch et al. J Virol. 1995 Mar.
Abstract
FrCasE is a highly neurovirulent murine leukemia virus which causes a noninflammatory spongiform neurodegenerative disease after neonatal inoculation. The central nervous system (CNS) infection is wide-spread, involving several different cell types, whereas the lesions are localized to motor areas of the brain and spinal cord. Inoculation of FrCasE at 10 days of age (P10) results in viremia, but infection of the CNS is restricted and neurological disease is not observed (M. Czub, S. Czub, F. McAtee, and J. Portis, J. Virol. 65:2539-2544, 1991). In this study, we used this developmental resistance to restrict the extent and the distribution of FrCasE in the brain to examine whether the spongiform degeneration is a consequence of infection of cells in proximity to the lesions. Two approaches were used to infect the brain on or after P10. First, mice were inoculated with FrCasE at P10 to induce viremia and then at P17 were subjected to focal CNS injury within brain regions known to be susceptible to virus-induced spongiform degeneration. The injury resulted in local inflammation, glial activation, migration of inflammatory cells into the wound site, and high-level parenchymal infection about the wound site. However, no evidence of spongiform neurodegeneration was observed over a period of 3 months. The second approach involved the implantation of FrCasE-infected microglia into the CNS at > or = P10. This resulted in microglial engraftment and focal CNS infection unilaterally at the implantation sites and bilaterally along white matter tracts of the corpus callosum and pons and in cells of the subventricular layers of the lateral cerebral ventricles. Strikingly, focal spongiform degeneration colocalized with the sites of infection. In contrast to the wounding experiments, the implantation model was not associated with an inflammatory response or significant glial activation. Results of these studies suggest that (i) the developmental resistance of the CNS to infection lies at the blood-brain barrier and can be bypassed by direct introduction into the brain of virus-infected cells, (ii) the neuropathology induced by this virus is a consequence of local effects of the infection and does not appear to require endothelial or neuronal infection, and (iii) elements of the inflammatory response and/or glial activation may modulate the expression of neuropathology induced by neurovirulent retroviruses.
Similar articles
- Gene expression profiling of microglia infected by a highly neurovirulent murine leukemia virus: implications for neuropathogenesis.
Dimcheff DE, Volkert LG, Li Y, DeLucia AL, Lynch WP. Dimcheff DE, et al. Retrovirology. 2006 May 12;3:26. doi: 10.1186/1742-4690-3-26. Retrovirology. 2006. PMID: 16696860 Free PMC article. - Kinetic analysis of spongiform neurodegenerative disease induced by a highly virulent murine retrovirus.
Czub S, Lynch WP, Czub M, Portis JL. Czub S, et al. Lab Invest. 1994 May;70(5):711-23. Lab Invest. 1994. PMID: 8196367 - Age-dependent resistance to murine retrovirus-induced spongiform neurodegeneration results from central nervous system-specific restriction of virus replication.
Czub M, Czub S, McAtee FJ, Portis JL. Czub M, et al. J Virol. 1991 May;65(5):2539-44. doi: 10.1128/JVI.65.5.2539-2544.1991. J Virol. 1991. PMID: 1850027 Free PMC article. - Differential glycosylation of the Cas-Br-E env protein is associated with retrovirus-induced spongiform neurodegeneration.
Lynch WP, Sharpe AH. Lynch WP, et al. J Virol. 2000 Feb;74(3):1558-65. doi: 10.1128/jvi.74.3.1558-1565.2000. J Virol. 2000. PMID: 10627570 Free PMC article. Review.
Cited by
- Rebound from Inhibition: Self-Correction against Neurodegeneration?
Sivaramakrishnan S, Lynch WP. Sivaramakrishnan S, et al. J Clin Cell Immunol. 2017 Apr;8(2):492. doi: 10.4172/2155-9899.1000492. Epub 2017 Mar 13. J Clin Cell Immunol. 2017. PMID: 28775912 Free PMC article. - Postinhibitory rebound neurons and networks are disrupted in retrovirus-induced spongiform neurodegeneration.
Li Y, Davey RA, Sivaramakrishnan S, Lynch WP. Li Y, et al. J Neurophysiol. 2014 Aug 1;112(3):683-704. doi: 10.1152/jn.00227.2014. Epub 2014 May 14. J Neurophysiol. 2014. PMID: 25252336 Free PMC article. - Retrovirus-induced spongiform neurodegeneration is mediated by unique central nervous system viral targeting and expression of env alone.
Li Y, Cardona SM, Traister RS, Lynch WP. Li Y, et al. J Virol. 2011 Mar;85(5):2060-78. doi: 10.1128/JVI.02210-10. Epub 2010 Dec 29. J Virol. 2011. PMID: 21191010 Free PMC article. - Long-lasting protective antiviral immunity induced by passive immunotherapies requires both neutralizing and effector functions of the administered monoclonal antibody.
Nasser R, Pelegrin M, Michaud HA, Plays M, Piechaczyk M, Gros L. Nasser R, et al. J Virol. 2010 Oct;84(19):10169-81. doi: 10.1128/JVI.00568-10. Epub 2010 Jul 7. J Virol. 2010. PMID: 20610721 Free PMC article.
References
- J Cell Biol. 1991 Jan;112(2):323-33 - PubMed
- Science. 1994 Aug 19;265(5175):1107-10 - PubMed
- J Clin Invest. 1991 Feb;87(2):503-12 - PubMed
- Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1281-5 - PubMed
- Am J Pathol. 1991 Mar;138(3):655-71 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases